Completed PHASE3 INTERVENTIONAL 2-arm NCT00312000

Sequential Versus Combination Chemotherapy in Advanced Colorectal Carcinoma

A Randomised Study of Sequential Versus Combination Chemotherapy in Patients With Previously Untreated Advanced Colorectal Carcinoma

Sponsor: Dutch Colorectal Cancer Group

Conditions Advanced Colorectal Cancer

Interventions capecitabine+irinotecan (1st line) capecitabine-irinotecan

Updated 5 times since 2017 Last updated: Sep 5, 2008 Started: Jan 31, 2003 Primary completion: Feb 28, 2006 Completion: Dec 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Advanced Colorectal Cancer and is currently completed. Dutch Colorectal Cancer Group leads this study, which shows 5 recorded versions since 2003 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dutch Colorectal Cancer Group
Hoffmann-La Roche
Koningin Wilhelmina Fonds
Sanofi

Data source: Dutch Colorectal Cancer Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.